Momentum is building to reevaluate the safety of pain relievers like Celebrex and Vioxx due to concerns about heart problems.
Researchers suggest that these drugs may block a substance that prevents heart issues.
The FDA is criticized for not investigating Vioxx's heart risks earlier.
Merck withdrew Vioxx from the market after studies showed increased heart attack risks.
Concerns about drug safety monitoring persist, with calls for more thorough testing.
The controversy highlights the need for stricter regulations and ongoing monitoring of approved medications.
